Valuation: Haemonetics Corporation

Market Cap 341.16Cr 298.24Cr 274.09Cr 255.48Cr 484.57Cr 32TCr 491.92Cr 3.29TCr 1.28TCr 16TCr 1.28TCr 1.25TCr 55TCr P/E 2027 *
19x
P/E 2028 * 16.8x
Enterprise Value 408.41Cr 357.03Cr 328.11Cr 305.84Cr 580.09Cr 39TCr 588.89Cr 3.94TCr 1.53TCr 19TCr 1.53TCr 1.5TCr 66TCr EV / Sales 2027 *
2.92x
EV / Sales 2028 * 2.58x
Free-Float
98.78%
Yield 2027 *
2.66%
Yield 2028 * -
1 day+0.29%
1 week-2.87%
Current month+0.09%
1 month+13.95%
3 months+32.10%
6 months-6.14%
Current year-6.34%
1 week 72.34
Extreme 72.34
77.68
1 month 69.64
Extreme 69.635
81.99
Current year 51
Extreme 51
86.11
1 year 47.32
Extreme 47.315
87.32
3 years 47.32
Extreme 47.315
97.97
5 years 43.5
Extreme 43.5
97.97
10 years 29.08
Extreme 29.08
142.11
Manager TitleAgeSince
Chief Executive Officer 62 16/05/2016
Director of Finance/CFO 55 11/04/2022
Chief Operating Officer 56 01/04/2025
Director TitleAgeSince
Director/Board Member 73 01/01/2006
Director/Board Member 71 23/07/2014
Director/Board Member 62 16/05/2016
Date Insider Type Main position Quantity % Market Cap.
05/06Tax

VP, Chief Accounting Officer

-259 0.0006%
05/06Tax

Head of Human Resources

-313 0.0007%
15/05Tax

Chief Executive Officer

-88,025 0.1894%
Change 5-day change 1-year change 3-year change Capi.($)
+0.29%-2.87%-2.34%-10.50% 341.16Cr
+3.49%+1.36%-29.04%-11.02% 17TCr
+5.04%+2.73%-5.88%-4.53% 11TCr
+2.80%+3.63%+0.09%+55.31% 5.77TCr
+1.33%+1.39%+53.16%+49.84% 5.38TCr
+3.39%+1.39%-10.26%-39.65% 4.36TCr
+3.50%+11.11% - - 3.65TCr
+3.47%+1.58%-14.08%-43.91% 2.75TCr
+0.20%+4.24%+64.56%-3.33% 2.58TCr
+2.78%+1.17%-8.15%-0.43% 2.13TCr
Average +2.63%+3.88%+5.34%-0.91% 5.42TCr
Weighted average by Cap. +3.29%+3.75%-3.83%+0.97%

Financials

2027 *2028 *
Net sales 140.04Cr 122.43Cr 112.51Cr 104.87Cr 198.91Cr 13TCr 201.93Cr 1.35TCr 525.08Cr 6.55TCr 525.67Cr 514.38Cr 23TCr 147.42Cr 128.87Cr 118.43Cr 110.39Cr 209.39Cr 14TCr 212.56Cr 1.42TCr 552.73Cr 6.9TCr 553.35Cr 541.47Cr 24TCr
Net income 17Cr 15Cr 14Cr 13Cr 25Cr 1.65TCr 25Cr 167.05Cr 65Cr 810.61Cr 65Cr 64Cr 2.79TCr 20Cr 18Cr 16Cr 15Cr 29Cr 1.93TCr 29Cr 195.84Cr 76Cr 950.36Cr 76Cr 75Cr 3.27TCr
Net Debt 67Cr 59Cr 54Cr 50Cr 96Cr 6.4TCr 97Cr 648.58Cr 252.13Cr 3.15TCr 252.42Cr 247Cr 11TCr 38Cr 34Cr 31Cr 29Cr 55Cr 3.66TCr 55Cr 371.14Cr 144.28Cr 1.8TCr 144.44Cr 141.34Cr 6.21TCr
Logo Haemonetics Corporation
Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.
Employees
3,009
Date Price Change Volume
02/26/02 $75.07 +0.29% 13,29,863
01/26/01 $74.85 -0.20% 6,36,819
30/26/30 $75.00 -0.16% 5,62,613
29/26/29 $75.12 -2.81% 6,12,908
26/26/26 $77.29 -0.43% 16,08,297
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
75.07USD
Average target price
85.20USD
Spread / Average Target
+13.49%

Quarterly revenue - Rate of surprise